Naider Avi Z.

Loxo Oncology, Inc.

Director

Avg. Two Year Performance

39% Avg. Purchase Return 18% Compound

No Sale Track Record

Holdings: 0 shares

Last Three Months: 27-Aug-24 -- 26-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

27-Nov-22 -- 26-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions